现代注射泵组件在围术期低流速下的性能评估
该体外研究评估了七种市售注射泵组件在1 ml h-1流速下启动、垂直位移和管路闭塞时的性能,并以药代动力学模拟计算新生儿持续输注肾上腺素时的血浆浓度。结果显示启动至稳态时间、零药物输送时间和闭塞报警延迟差异大,所有组件在垂直位移时的流速异常均导致模拟血浆肾上腺素浓度偏差超过25%。
要点
- 低流速下注射泵启动延迟和闭塞报警延迟显著,影响药物输送准确性。
- 垂直位移 manoeuvres 引起的流速异常可导致血浆药物浓度偏差超过25%。
- 现有注射泵的功能原理缺陷仅靠设备渐进改进难以完全解决。
核心结论
- 注射泵组件性能问题在低流速输注高浓度短效心血管药物时对血浆药物浓度有显著影响。
研究设计与样本
- 体外研究评估七种市售注射泵组件在1 ml h-1流速下的启动、垂直位移和闭塞性能,并以药代动力学模拟新生儿持续肾上腺素输注的血浆浓度。
主要发现
- 启动至稳态流速的平均时间范围为89至1622秒。
- 降低泵后零药物输送时间范围为145至335秒。
- 所有测试组件在垂直位移时的闭塞报警延迟和流速异常导致模拟血浆肾上腺素浓度偏差大于25%。
临床怎么用
- 在低流速输注高浓度短效心血管药物时,应认识到注射泵性能问题可能显著影响血浆药物浓度。
局限性
- 问题主要与注射泵功能原理相关,仅靠现有设备的渐进改进只能部分解决。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Syringe infusion pumps are used for the precise continuous administration of intravenous drugs. Their compliance and mechanical deficiencies have been found to cause considerable start-up delays, flow irregularities during vertical displacement, as well extensive delays of occlusion alarms at low infusion rates. The aim of this study was to evaluate the performance of several modern syringe infusion pumps at low infusion rates and the impact on drug concentration. METHODS: Seven currently marketed syringe infusion pump assemblies were assessed in an in vitro study during start-up, vertical displacement manoeuvres, and infusion line occlusion at a set flow rate of 1 ml h-1. The measured data were used as input for a pharmacokinetic simulation modelling plasma concentration during a standard neonatal continuous epinephrine infusion. RESULTS: The mean time from starting the infusion pump to steady-state flow varied from 89 to 1622 s. The zero-drug delivery time after lowering the pump ranged from 145 to 335 s. In all assemblies tested, occlusion alarm delays and measured flow irregularities during vertical displacement manoeuvres resulted in relevant deviations in plasma epinephrine concentration (>25%) as calculated by the pharmacokinetic simulation model. CONCLUSION: Problems with the performance of syringe infusion pump assemblies can have considerable impact on plasma drug concentration when highly concentrated short-acting cardiovascular drugs are administered at low flow rates. The problems, which affected all assemblies tested, are mainly related to the functional principle of syringe infusion pumps and will only partially be solved by incremental improvements of existing equipment.
引用
- Baeckert M, Batliner M, Grass B, et al. Performance of modern syringe infusion pump assemblies at low infusion rates in the perioperative setting. Br J Anaesth. 2019. PMID: 31864721. doi:10.1016/j.bja.2019.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。